Links to 5 Hepatitis C Articles

[Guest guest]

Change in agreement regarding additional purchase consideration for Multiferon®

Reuters (press release)

A new agreement has been signed regarding the additional purchase consideration

for Multiferon and the hepatitis C clinical study which was included in the

agreement with the sellers upon Biovitrum's acquisition of Swedish Orphan 2009.

....

See all stories on this topic » NEW TRANSPLANT TOOL: Smartphone images of donor

organs can speed critical ...

London Free Press

Days earlier, a 56-year-old man with hepatitis C had been taken to a London

hospital with his liver failing, joining a waiting list that for some becomes a

death sentence because they die before an organ is found. On a scale of 1 to 40,

with 40 being ...

See all stories on this topic »

More Than Two-Thirds of Surveyed U.S. Clinicians Plan to Prescribe Incivek and

....

Business Wire (press release)

In May 2011, Incivek and Victrelis were approved as treatments for hepatitis C

virus by the US Food and Drug Administration. “Additionally, only 11 percent of

surveyed clinicians expect to prescribe Victrelis over Incivek—of this small

minority, ...

See all stories on this topic »Possible Drug Targets for Hepatitis C Virus as P7

Protein Resistance Mutations ...

MedIndia

by Kathy on June 30, 2011 at 10:05 PM Specific resistance mutations for

two classes of p7 inhibitor, which may explain their lack of effectiveness in

clinical trials combined with current standard of care have been identified by

Brit researchers. ...

See all stories on this topic » Fewer Complications With NAFLD Than Hepatitis C

Virus

Doctors Lounge

Patients with nonalcoholic fatty liver disease with advanced fibrosis or

cirrhosis may have fewer liver-related complications and less hepatocellular

cancer than patients with hepatitis C virus infection, but may have similar

overall mortality, ...

See all stories on this topic »

[Guest guest]

Change in agreement regarding additional purchase consideration for Multiferon®

Reuters (press release)

A new agreement has been signed regarding the additional purchase consideration

for Multiferon and the hepatitis C clinical study which was included in the

agreement with the sellers upon Biovitrum's acquisition of Swedish Orphan 2009.

....

See all stories on this topic » NEW TRANSPLANT TOOL: Smartphone images of donor

organs can speed critical ...

London Free Press

Days earlier, a 56-year-old man with hepatitis C had been taken to a London

hospital with his liver failing, joining a waiting list that for some becomes a

death sentence because they die before an organ is found. On a scale of 1 to 40,

with 40 being ...

See all stories on this topic »

More Than Two-Thirds of Surveyed U.S. Clinicians Plan to Prescribe Incivek and

....

Business Wire (press release)

In May 2011, Incivek and Victrelis were approved as treatments for hepatitis C

virus by the US Food and Drug Administration. “Additionally, only 11 percent of

surveyed clinicians expect to prescribe Victrelis over Incivek—of this small

minority, ...

See all stories on this topic »Possible Drug Targets for Hepatitis C Virus as P7

Protein Resistance Mutations ...

MedIndia

by Kathy on June 30, 2011 at 10:05 PM Specific resistance mutations for

two classes of p7 inhibitor, which may explain their lack of effectiveness in

clinical trials combined with current standard of care have been identified by

Brit researchers. ...

See all stories on this topic » Fewer Complications With NAFLD Than Hepatitis C

Virus

Doctors Lounge

Patients with nonalcoholic fatty liver disease with advanced fibrosis or

cirrhosis may have fewer liver-related complications and less hepatocellular

cancer than patients with hepatitis C virus infection, but may have similar

overall mortality, ...

See all stories on this topic »